LIPI

OMIMHGNC

Synonym(s): PRED5, LPDL, CT17, mPA-PLA1beta, PLA1C

Locus: 21q11.2

Protein: Membrane-associated phospholipase A1 beta deltaE5

 

Disorders

Tests

Test Type
Molecular (5)
Multi-Gene Panel (1)
Multi-Method Panel (2)
Test Method
Del/Dup (CNV) (1)
Sequencing, Capillary (Sanger) (4)
Sequencing, Next Gen (2)
Prenatal/Carrier
Carrier (1)
Lab Location
Spain(2)
Portugal(1)
USA(1)
Germany(1)
 
Major Hypertriglyceridemia, Sequencing LIPI Gene
method(s): ◦ Sequencing, Capillary (Sanger) 
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain
Major Hypertriglyceridemia, Panel Massive Sequencing (NGS) (LPL, APOA5,APOC2,LIPI,GPIHBP1,LMF1) Genes
method(s): ◦ Sequencing, Next Gen 
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain
Hyperlipoproteinemia type 4 (sequence analysis of LIPI gene)
method(s): ◦ Sequencing, Capillary (Sanger) 
CGC Genetics - Porto, Portugal
TAT: 4-5 Weeks
price: contact lab
LIPI
method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) 
Fulgent Diagnostics - Temple City, CA, USA
TAT: ~2 weeks
price: contact lab
Hypertriglyceridemia, susceptibility to
method(s): ◦ Sequencing, Capillary (Sanger) 
Centogene AG, Rare Disease Company - Rostock, Germany